NZX-listed Fisher & Paykel Healthcare said its net profit
rose by 18 per cent to $33.3 million for the six months to
September 30, compared with the previous corresponding
period, and that it was heading towards an improved
performance for the full financial year.
In constant currency terms, the company's operating profit
grew by 46 per cent in the six monnths, mostly as a result of
revenue growth, improved gross margins and operating
efficiencies, the specialised medical equipment maker said.
Operating revenue was a record $266.9 million - up 6 per cent
from the same period last year.
The company's respiratory and acute care product group
operating revenue increased by 11 per cent and obstructive
sleep apnea product group revenue increased by 3 per cent in
constant currency terms. F&P Healthcare announced an
interim dividend of 5.4c, unchanged.
F&P Healthcare said it expects operating revenue in the
2012-13 year to be in a range of $545m to $555m and its net
profit to be in a range of $69m to $72m - up $3m to $4m on
the guidance provided at the its annual meeting in August.
The company's net profit was $64.1 million in the 2011-12